Loading
Pharmanutra CS - Pharmanutra - PHN - Cetilar AL Fianco di Fernando Alonso Stock: price and insider trades · Italy
Pharmanutra CS - Pharmanutra - PHN - Cetilar AL Fianco di Fernando Alonso: what insiders have been doing
Insider filings for Pharmanutra CS - Pharmanutra - PHN - Cetilar AL Fianco di Fernando Alonso are scarce in the Consob feed, the latest one published on 26 May 2023. This page will fill in as new trades are disclosed. These figures are compiled from regulatory filings published by Consob. They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 7,140 of 24,161 companies
61.8
score / 100
Value39
Quality85
FCF yld2.1%
Earn yld2.5%
EV/EBITDA23.8x
ROE30%
Gross mgn77%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€83.00
Analyst consensus
3 analysts1.00/5
€76.00Target €81.33(-2%)€86.00
Income statement
Revenue€132.9M
Gross profit€102.9M77% margin
EBITDA€34.3M26% margin
Net income€20.0M15.1% margin
Valuation
PER (trailing)37.7x
PER (forward)27.1x
P/Book10.7x
Beta0.17
Balance sheet & cash
Market cap€794.7M
Total debt€20.5M
Free Cash Flow€16.4M
Debt / Equity26%
Profitability & ownership
ROE30.1%
ROA15.2%
% insiders65.0%
% institutions17.2%
Last declaration on 26 May 2023
About Pharmanutra CS - Pharmanutra - PHN - Cetilar AL Fianco di Fernando Alonso
Pharmanutra is a company specialized in the health and pharmaceutical sector, known for its innovative products. It is listed on the XMIL market and is associated with the Cetilar brand, supported by Formula 1 driver Fernando Alonso.
